ArticleCase reports in oncological medicine2025

Vedolizumab Dose Escalation Resolves Immune Checkpoint Inhibitor-Induced Colitis in Two Patients.

Cong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.